Moleculin Biotech, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Moleculin Biotech, Inc. (MBRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 1.20 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-03-18
- Moleculin Biotech, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-12-31 was -16.67K shares.
- Moleculin Biotech, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-09-30 was 0.00 shares.
- Moleculin Biotech, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-12-31 was 0.00 shares.
- Moleculin Biotech, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2018-12-31 was 0.00 shares.
- Moleculin Biotech, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 1.20K shares, a 81.93% decline from fiscal 2024.
- Moleculin Biotech, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 6.66K shares, a 84.60% increase from fiscal 2023.
- Moleculin Biotech, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 3.61K shares, a 38.12% decline from fiscal 2022.
- Moleculin Biotech, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 5.83K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 1.20K shares 10-K · filed 2026-03-18 | |||
| 2024-12-31 | 6.66K shares 10-K · filed 2025-03-21 | |||
| 2023-12-31 | 3.61K shares 10-K · filed 2024-03-22 | |||
| 2022-12-31 | 5.83K shares 10-K · filed 2023-03-22 | |||
| 2021-12-31 | 0.00 shares 10-K · filed 2022-03-24 | |||
| 2020-12-31 | -16.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | -16.67K shares derived: sum of 2 quarters · filed 2021-03-24 | 3.33K shares 10-K · filed 2021-03-24 | |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 20.00K shares 10-Q · filed 2020-11-12 | ||
| 2020-06-30 | 20.00K shares 10-Q · filed 2020-08-12 | |||
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | 103.00K shares 10-K · filed 2020-03-19 | ||
| 2019-09-30 | 103.00K shares 10-Q · filed 2019-11-12 | |||
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | 5.00K shares 10-K · filed 2019-02-21 | ||
| 2018-09-30 | 5.00K shares 10-Q · filed 2018-11-13 | |||
| 2017-12-31 | 0.00 shares 10-K · filed 2018-03-28 | |||
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-12 | 0.00 shares derived: sum of 2 quarters · filed 2018-03-28 | ||
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | 150.00K shares 10-K · filed 2018-03-28 | ||
| 2016-09-30 | 150.00K shares 10-Q · filed 2016-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |